Key stakeholders’ perspectives on implementation of risk-based population breast cancer screening in Australia – “We can either get on the bus or get under it”
Key stakeholders in Australia were overwhelmingly enthusiastic about the benefits of a risk-based approach however there are concerns about risk assessment utility, cost and the potential risk to equity in the program. Systematic assessment of these concerns will be required to facilitate successful change to the well-established breast screening program in Australia should risk-stratification be undertaken.
Authors
- Louise Anne Keogh (ORCID: https://orcid.org/0000-0003-2963-6451)
- Jocelyn Lippey (ORCID: https://orcid.org/0000-0001-9977-1646)
- Laura Forrest (ORCID: https://orcid.org/0000-0002-1126-4971)
- G. Bruce Mann (ORCID: https://orcid.org/0000-0002-2508-9203)
- Stephanie Best (ORCID: https://orcid.org/0000-0002-1107-8976)
- Rebecca Purvis (ORCID: https://orcid.org/0000-0002-1338-1098)
Institutions
- The Royal Melbourne Hospital (AU)
- The University of Melbourne (AU)
- Peter MacCallum Cancer Centre (AU)
- St Vincent's Hospital Melbourne (AU)
- Murdoch Children's Research Institute (AU)
- Melbourne Health (AU)
Publication Details
- Journal
- Archives of Public Health
- Published
- 2025-09-01
- DOI
- https://doi.org/10.1186/s13690-025-01690-5
- Primary Topic
- Global Cancer Incidence and Screening
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Victorian Cancer Agency
- Marshfield Clinic Research Foundation